Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA)

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified March 2015 by Population Health Research Institute
Sponsor:
Collaborators:
Bristol-Myers Squibb
Pfizer
Medtronic
Information provided by (Responsible Party):
Jeff Healey, Population Health Research Institute
ClinicalTrials.gov Identifier:
NCT01938248
First received: September 4, 2013
Last updated: March 13, 2015
Last verified: March 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: July 2019
  Estimated Primary Completion Date: April 2019 (Final data collection date for primary outcome measure)